Shire (SHPGF) Short-Term Capital Lease Obligation : $10 Mil (As of Sep. 2018)

View and export this data going back to . Start your Free Trial

What is Shire Short-Term Capital Lease Obligation?

Shire's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2018 was $10 Mil.

Shire's quarterly Short-Term Capital Lease Obligation increased from Mar. 2018 ($0 Mil) to Jun. 2018 ($8 Mil) and increased from Jun. 2018 ($8 Mil) to Sep. 2018 ($10 Mil).

Shire's annual Short-Term Capital Lease Obligation increased from Dec. 2015 ($0 Mil) to Dec. 2016 ($6 Mil) and increased from Dec. 2016 ($6 Mil) to Dec. 2017 ($8 Mil).

Shire Short-Term Capital Lease Obligation Historical Data

The historical data trend for Shire's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Short-Term Capital Lease Obligation Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

6.40

7.50

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															7.00	7.50	-	8.30	9.50

Shire Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Shire Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shire's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shire (SHPGF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (OTCPK:SHPGF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.